Earnings Data
Report Date
Nov 05, 2026TBA (Confirmed)
Period Ending
2026 (Q3)Consensus EPS Forecast
-0.1Last Year’s EPS
-0.1Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
DE:GX1 Q2 2026 Earnings Report
DE:GX1 Upcoming Earnings
Marker Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
DE:GX1 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:GX1 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 19, 2026 | €0.85 | €0.84 | -1.75% |
May 20, 2026 | €1.04 | €1.05 | +0.96% |
Mar 18, 2026 | €1.03 | €1.02 | -0.97% |
Nov 14, 2025 | €0.67 | €0.61 | -7.52% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Marker Therapeutics Inc (DE:GX1) report earnings?
Marker Therapeutics Inc (DE:GX1) is schdueled to report earning on Nov 05, 2026, TBA (Confirmed).
What is Marker Therapeutics Inc (DE:GX1) earnings time?
Marker Therapeutics Inc (DE:GX1) earnings time is at Nov 05, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Marker Therapeutics Inc stock?
The P/E ratio of Marker Therapeutics is N/A.
What is DE:GX1 EPS forecast?
DE:GX1 EPS forecast for the fiscal quarter 2026 (Q3) is -0.1.